Basu P K, Avaria M, Matuk Y, Carre F, Kapur B M
Can J Ophthalmol. 1986 Aug;21(5):162-6.
The purpose of the study was to determine chronologically the ocular distribution of methyprylon (Noludar) after a single intravenous injection (45 mg/kg) to rabbits, if the drug can be transferred from a donor treated with the drug to the recipient's eye via an allogeneic corneal graft, and the effect of methyprylon on corneal cell growth and protein synthesis. Gas chromatographic techniques showed that the drug was present in all the tissues and fluids of the eye from 0.5 to 18 hours after the injection. Postoperatively, the cornea and some of the other ocular tissues of the recipient contained methyprylon at least 24 hours after transplantation. Clinically, the graft remained clear, and there was no adverse reaction in the recipient eye for an observation period of 24 hours. Tissue culture studies showed that about 10 times more methyprylon than was found in the donor cornea was necessary to produce a cytotoxic reaction on the corneal cells in terms of cellular growth rate and protein synthesis. Our animal experiments and cytotoxicity tests suggest that corneas of donors treated with a high dose of methyprylon would be suitable for use as grafts.
本研究的目的是按时间顺序确定给兔子单次静脉注射(45毫克/千克)美普眠(诺卢德)后其在眼部的分布情况,该药物是否能通过同种异体角膜移植从用药供体转移至受体眼中,以及美普眠对角膜细胞生长和蛋白质合成的影响。气相色谱技术表明,注射后0.5至18小时,该药物存在于眼的所有组织和液体中。术后,受体的角膜和其他一些眼部组织在移植后至少24小时含有美普眠。临床上,移植物保持透明,在24小时的观察期内受体眼未出现不良反应。组织培养研究表明,就细胞生长速率和蛋白质合成而言,要对角膜细胞产生细胞毒性反应,所需的美普眠量约为供体角膜中含量的10倍。我们的动物实验和细胞毒性试验表明,用高剂量美普眠处理过的供体角膜适合用作移植物。